Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001104659-25-081954
Filing Date
2025-08-22
Accepted
2025-08-22 17:19:47
Documents
20

Document Format Files

Seq Description Document Type Size
1 FORM F-3 tm2524155d1_f3.htm F-3 244898
2 EXHIBIT 5.1 tm2524155d1_ex5-1.htm EX-5.1 24570
3 EXHIBIT 5.2 tm2524155d1_ex5-2.htm EX-5.2 21711
4 EXHIBIT 23.1 tm2524155d1_ex23-1.htm EX-23.1 3337
5 EX-FILING FEES tm2524155d1_exfilingfees.htm   iXBRL EX-FILING FEES 42034
6 GRAPHIC tm2524155d1_ex5-1img001.jpg GRAPHIC 3093
7 GRAPHIC tm2524155d1_ex5-1img002.jpg GRAPHIC 1834
8 GRAPHIC tm2524155d1_ex5-2img001.jpg GRAPHIC 11826
9 GRAPHIC tm2524155d1_f3img02.jpg GRAPHIC 6926
  Complete submission text file 0001104659-25-081954.txt   544050

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2524155d1_exfilingfees_htm.xml XML 13936
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-289819 | Film No.: 251247221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)